Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study supplements patients' current medications with Pravastatin, a cholesterol-lowering
medication, to try to improve residual symptoms of schizophrenia, and also to improve
cognitive functioning.